Investors

Webcast ImageWebcast
Q4 2016 Edge Therapeutics, Inc. Earnings Conference Call (Live)
March 2, 2017 at 8:30 a.m. ET
Q4 2016 Edge Therapeutics, Inc. Earnings Conference Call
Thursday, March 2, 2017 8:30 a.m. ET  
Webcast PresentationHelp Help
Click here for webcast
Add to CalendarHelp Help
Add to Calendar Click here to add this event to your calendar
Webcast ImageWebcast
Edge Therapeutics, Inc. RBC Capital Markets 2017 Healthcare Conference (Replay)
February 23, 2017 at 8:00 a.m. ET
Edge Therapeutics, Inc. RBC Capital Markets 2017 Healthcare Conference
Thursday, February 23, 2017 8:00 a.m. ET  
Webcast PresentationHelp Help
Click here for webcast
Add to CalendarHelp Help
Add to Calendar Click here to add this event to your calendar
Webcast ImageWebcast
Edge Therapeutics, Inc. at LEERINK Partners 6th Annual Global Healthcare Conference (Replay)
February 15, 2017 at 1:30 p.m. ET
Edge Therapeutics, Inc. at LEERINK Partners 6th Annual Global Healthcare Conference
Wednesday, February 15, 2017 1:30 p.m. ET  
Webcast PresentationHelp Help
Click here for webcast
Add to CalendarHelp Help
Add to Calendar Click here to add this event to your calendar

Corporate Profile

Edge Therapeutics is a clinical-stage biotechnology company that discovers, develops and seeks to commercialize novel, hospital-based therapies capable of transforming treatment paradigms in the management of acute, life-threatening conditions.

We believe EG-1962, our lead product candidate, can fundamentally improve patient outcomes and transform the management of aneurysmal subarachnoid hemorrhage, or aSAH, which is bleeding around the brain due to a ruptured brain aneurysm. Read More

Lastest News

February 23, 2017 - Edge Therapeutics Announces Conference Call on March 2, 2017 to Discuss Fourth Quarter and Full Year 2016 Financial Results
Read More
February 21, 2017 - Edge Therapeutics Appoints Alyssa Wyant as Senior Vice President, Regulatory Affairs and Makes Inducement Grant under NASDAQ Rule 5635(c)(4)
Read More
February 17, 2017 - Edge Therapeutics’ EG-1962 Data To Be Presented at International Stroke Conference 2017
Read More

Upcoming Events

DateTitle
March 2, 2017 8:30 a.m. ET
Q4 2016 Edge Therapeutics, Inc. Earnings Conference Call

Stock Information

EDGE (Common Stock)
ExchangeNASDAQ GS (US Dollar)
Price$10.09
Change (%) Stock is Up 0.09 (0.90%)
Volume12,235
Data as of February 24, 2017 4:00 p.m. ET
Refresh quote

IR Contact

Gregory Gin
Email: ir@edgetherapeutics.com

Data provided by Nasdaq. Minimum 15 minutes delayed.

Printer Friendly Version Print PageE-mail this page Email PageRSS RSS FeedsE-mail Alerts Email AlertsView contacts IR ContactsDownload Financial Tear Sheet Financial Tear Sheet